FDA expands access to research MDMA for PTSD treatment
For decades, MDMA has been considered a party drug. But, after years of research and clinical trials, one organization is convincing government officials and patients that the drug can also be beneficial in the treatment of post-traumatic stress disorder (PTSD). The Multidisciplinary Association for Psychedelic Studies (MAPS) recently announced they had received “expanded access” approval...